Long-Lasting Response to Lorlatinib in Patients with ALK-Driven Relapsed or Refractory Neuroblastoma Monitored with Circulating Tumor DNA Analysis
通过循环肿瘤 DNA 分析监测 ALK 驱动的复发或难治性神经母细胞瘤患者对劳拉替尼的长期反应
期刊:Cancer Research Communications
影响因子:2
doi:10.1158/2767-9764.CRC-24-0338
Torben Ek #, Raghda R Ibrahim #, Hartmut Vogt, Kleopatra Georgantzi, Catarina Träger, Jennie Gaarder, Anna Djos, Ida Rahmqvist, Elisabeth Mellström, Fani Pujol-Calderón, Christoffer Vannas, Lina Hansson, Henrik Fagman, Diana Treis, Susanne Fransson, Tobias Österlund, Tzu-Po Chuang, Bronte Manouk Ver
